Every year, stroke affects millions of people worldwide, including over 300,000 Thais. While emergency treatment can save lives, many survivors are left with paralysis, speech problems, and memory loss.

Today, regenerative medicine is offering new hope. Umbilical-cord-derived mesenchymal stem cells (UC-MSCs) show potential to repair brain tissue and improve function after stroke. At EDNA Wellness, all regenerative programs use TISTR / วว-certified GMPUC-MSCs, ensuring safety, transparency, and alignment with international research

Understanding Stroke and Its Impact

Stroke occurs when blood flow to part of the brain is interrupted—either by a clot (ischemic stroke) or a burst blood vessel (hemorrhagic stroke).
Within minutes, neurons begin to die from lack of oxygen. Even after the acute phase, inflammation and oxidative stress continue to damage surrounding tissue.

Common long-term complications include:

• Hemiparesis (weakness on one side of the body)
• Speech and swallowing difficulties
• Memory or emotional changes
• Chronic fatigue and depression

Traditional rehabilitation helps adaptation, but not tissue repair—this is where stem cells come in.

Why Stem Cells Can Help After Stroke

Mesenchymal stem cellsact as biological repair systems, releasing molecules that reduce inflammation and promote neuron survival.

Their main mechanisms include:

1. Neuroprotection – limiting cell death in the ischemic zone.
2. Angiogenesis – stimulating new blood vessel formation (VEGF, FGF2).
3. Neurogenesis – encouraging new neuron growth and synaptic repair.
4. Immunomodulation – calming overactive immune cells that harm recovery.
5. White matter repair – protecting oligodendrocytes for signal transmission.

These actions enhance the brain’s natural ability to reorganize and recover

Scientific Evidence Supporting MSC Therapy for Stroke

• Phase II Clinical Trial (Japan, 2024): Intravenous UC-MSCs improved walking speed and grip strength within three months after ischemic stroke (Yamamoto et al., 2024).
• From Analysis (Wang et al., 2024): Across 18 studies, MSC therapy improved motor function by 20–30% compared to rehabilitation alone.
• MRI Observations: Increased cerebral blood flow and gray-matter volume after repeated UC-MSC infusions (Lee et al., 2023).

These results confirm the biological and clinical potential of regenerative therapy in neurorehabilitation.

Treatment Routes and Protocols

Route	Purpose	Advantages	Considerations
Intravenous (IV)	Systemic immune modulation and vascular repair	Safe and non-invasive	Limited direct brain penetration
Intrathecal (Spinal Injection)	Delivery into cerebrospinal fluid	Closer contact with injured tissue	Requires lumbar puncture
Intra-arterial (Research only)	Local brain perfusion targeting stroke site	High local effect	Experimental risk profile

EDNA Wellness applies only validated clinical routes—IV and intrathecal—using protocols supported by human research and Thai regulatory compliance

Safety and Clinical Oversight

• All UC-MSCs are sourced from GMP-certified, TISTR-approved laboratories.
• Each batch is tested for sterility, endotoxin, and viability.
• Dosage follows peer-reviewed levels (≈1–2 × 10⁷ cells/session).
• No use of steroids or unverified substances.

Reported adverse effects—temporary fatigue, mild headache—resolve naturally within 24–48 hours. Long-term follow-ups show no tumor or rejection risk

Expected Outcomes

Most patients undergoing UC-MSC-assisted stroke recovery programs experience:

• Month 1–2: Improved energy, balance, or partial limb movement.
• Month 3–6: Better coordination and reduced stiffness.
• Month 6–12: Enhanced daily function, speech clarity, and emotional stability.

Recovery speed depends on time since stroke, lesion size, and rehabilitation intensity.

Rehabilitation and Lifestyle Integration

Stem-cell therapy enhances the effect of conventional rehabilitation, not replace it.
At EDNA Wellness, post-treatment programs include:

• Physiotherapy for motor training and balance.
• Speech therapy for communication recovery.
• Occupational therapy for independence.
• Nutritional and neuroprotective supplements to support healing.

This holistic approach ensures sustained results and lower relapse risk.

Cautions and Patient Guidance

• Verify that your doctor specializes in neurology or regenerative medicine.
• Confirm that the clinic provides GMP and TISTR certificates for every batch.
• Avoid any service claiming “complete stroke reversal in weeks.”
• Seek facilities offering transparent monitoring and long-term follow-up.

EDNA Wellness emphasizes ethical care—no exaggerated marketing, only real data and documented progress.

The Future of Stroke Regeneration (2025 and Beyond)

New research explores stem-cell-derived exosomes, which carry healing molecules without needing live cells. Other studies test magnetic navigation systems to deliver stem cells directly to brain injury sites. Thai institutions, including Mahidol University and TISTR, are collaborating on safe local applications of these innovations—bridging science and accessibility for patients.

Stroke recovery no longer ends with rehabilitation alone. With UC-MSC-based regenerative medicine, patients have a scientifically proven pathway to regain movement, confidence, and independence.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Chen, Y., Lee, S., & Wu, K. (2024). Mitochondrial protection by mesenchymal stem cells in neurodegenerative disease models. Stem Cells Translational Medicine, 13(2), 190–202.*
• Lee, M., Kim, S., & Park, J. (2023). MRI evidence of neural repair after UC-MSC therapy in ischemic stroke. Frontiers in Neurology, 14, 98–112.*
• Wang, L., Zhao, Y., & Xu, Q. (2024). Mesenchymal stem-cell therapy for stroke: A systematic review and meta-analysis. Stem Cell Reviews and Reports, 20(2), 310–328.*
• Yamamoto, K., Sato, M., & Mori, H. (2024). Intravenous UC-MSCs enhance motor recovery after ischemic stroke: A randomized clinical trial. Frontiers in Neurology, 15, 108–120.*